Tag: Soundbite Medical

Soundbite Medical Solutions Announces Issuance of Two New U.S. Patent Further Expanding Coverage of its Shock Wave Technology

Peripheral/Endo by 0 comments

MONTREAL–(BUSINESS WIRE)–Soundbite Medical Solutions Inc. (SBMS), a medical device company leveraging its proprietary shock wave technology for the interventional treatment of calcific occlusive peripheral and coronary arterial diseases, today announced that the United States Patent and Trademark Office has issued two additional […]

Continue Reading →

Soundbite Medical Announces Issuance Of A Fifth U.S. Patent Covering Novel Active Balloon Devices Intended For Plaque Modification Of Calcified Arteries

Peripheral/Endo by 0 comments

MONTREAL–(BUSINESS WIRE)–Soundbite Medical Solutions Inc. (SBMS), a medical device company dedicated to developing solutions for the interventional treatment of calcific occlusive peripheral and coronary arterial diseases, today announced that the United States Patent and Trademark Office has issued US patent No. 11,179,169, […]

Continue Reading →

Soundbite Medical’s Proprietary Shock Wave Technology Now Cracks Calcium In Germany, a Promising Solution for CLI Patients

Peripheral/Endo by 0 comments

MONTREAL–(BUSINESS WIRE)–Soundbite Medical Solutions Inc. (SBMS), a medical device company dedicated to developing solutions for the interventional treatment of calcific peripheral and coronary arterial diseases, today announced the use of its novel Active Wire 0.014” platform at a prominent site in Germany […]

Continue Reading →

Soundbite Medical Solutions Announces FDA Approval for SoundBite® Crossing System – Peripheral (14P)

Peripheral/Endo Regulatory by 0 comments

MONTREAL–(BUSINESS WIRE)–Soundbite announces FDA 510(k) Approval for SoundBite® Crossing System – Peripheral (SCS-P) with the 0.014” Active Wire (14P). The SoundBite® Crossing System – Peripheral (14P) is a recanalization tool, designed to help physician’s placement of conventional guidewires or treatment devices […]

Continue Reading →